A Study of OV101 in Individuals With Angelman Syndrome (AS)
Condition: Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Interventions: Drug: Gaboxadol; Drug: Placebo Sponsor: Ovid Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials